Finance

Lists
RGEN:NASDAQ
Repligen Corp
၁၉၄.၅၇ US$
+၀.၂၅%
(+၀.၄၈) 1D
၁၉၄.၅၇ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: စက် ၂၉, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGEN...
Open
၁၉၆.၀၀ US$
High
၁၉၆.၆၅ US$
Low
၁၉၀.၉၈ US$
Mkt. cap
ဋေ ၁.၁၀ ထ
Avg. vol.
၁.၀၆ သန်း
Volume
၁.၁၄ သန်း
P/E ratio
၂၆၅.၂၂
52-wk high
၁၉၈.၈၆ US$
52-wk low
၁၀၀.၉၉ US$
EPS
၀.၇၃ US$
Beta
၁.၀၅
Shares outstanding
၅.၆၄ ကုဋေ
No. of employees
၂ ထောင်
Open
၁၉၆.၀၀ US$
High
၁၉၆.၆၅ US$
Low
၁၉၀.၉၈ US$
Mkt. cap
ဋေ ၁.၁၀ ထ
Avg. vol.
၁.၀၆ သန်း
Volume
၁.၁၄ သန်း
P/E ratio
၂၆၅.၂၂
52-wk high
၁၉၈.၈၆ US$
52-wk low
၁၀၀.၉၉ US$
EPS
၀.၇၃ US$
Beta
၁.၀၅
Shares outstanding
၅.၆၄ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၈ နာရီ
Repligen stock price target reaffirmed at $225 by UBS on growth outlook
Stocktwits
Stocktwits
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?
Investing.com UK
Investing.com UK
·
ပြီးခဲ့သည့် ၁ ရက်
Form 4 Repligen Corporation For: 28 September By Investing.com
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees၂ ထောင်
Founded၁၉၈၁
HeadquartersWaltham, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 12 analysts giving stock ratings to RGEN in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for RGEN in the last 3 months.
Highest
Current ၁၉၄.၅၇ US$
၂၂၅.၀၀ US$ (+၁၅.၆၄%)
Average
၁၈၁.၆၇ US$ (-၆.၆၃%)
Lowest
၁၄၅.၀၀ US$ (-၂၅.၄၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Doug Schenkel
UBS
Buy
Maintained
၂၂၅.၀၀ US$
+၁၅.၆%
09/29/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
09/25/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
-
-
09/15/2026
Unknown Analyst
UBS
Buy
Maintained
၂၂၅.၀၀ US$
+၁၅.၆%
09/09/2026
Evan Stampler
Wells Fargo
Buy
Maintained
၁၈၅.၀၀ US$
-၄.၉%
08/16/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
၁၈၅.၀၀ US$
-၄.၉%
07/30/2026
Kyle Mikson CFA
Canaccord Genuity
Hold
Maintained
၁၄၅.၀၀ US$
-၂၅.၅%
07/28/2026
Casey Woodring
J.P. Morgan
Buy
Reiterated
၁၇၅.၀၀ US$
-၁၀.၁%
07/29/2026
Dan Leonard
RBC Capital
Buy
Reiterated
၁၈၅.၀၀ US$
-၄.၉%
07/28/2026
Brendan Smith
TD Cowen
Buy
Maintained
၂၀၀.၀၀ US$
+၂.၈%
07/28/2026
Matt Larew
William Blair
Buy
Maintained
-
-
07/28/2026
Luke Sergott
Barclays
Buy
Maintained
၁၇၅.၀၀ US$
-၁၀.၁%
07/28/2026
Robert Wasserman
StoneX
Buy
Upgraded
၁၈၅.၀၀ US$
-၄.၉%
07/07/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Maintained
၁၆၀.၀၀ US$
-၁၇.၈%
07/06/2026
Yessica Sanchez Gudino
HSBC
Buy
Maintained
၁၅၀.၀၀ US$
-၂၂.၉%
06/03/2026
Unknown Analyst
HSBC
Buy
Maintained
၁၅၀.၀၀ US$
-၂၂.၉%
06/03/2026
Michael Polark
Wolfe Research
Buy
Initiated
၁၄၅.၀၀ US$
-၂၅.၅%
06/01/2026
Unknown Analyst
RBC Capital
Buy
Initiated
၁၆၀.၀၀ US$
-၁၇.၈%
05/14/2026
Unknown Analyst
Guggenheim
Hold
Reiterated
-
-
05/07/2026
Matthew Stanton, CFA
Jefferies
Hold
Maintained
၁၄၂.၀၀ US$
-၂၇%
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Initiated
၁၆၀.၀၀ US$
-၁၇.၈%
04/17/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
၂၀၈.၀၀ US$
+၆.၉%
03/23/2026
Subbu Nambi
Guggenheim
Hold
Maintained
-
-
02/24/2026
Paul Knight
KeyBanc
Buy
Maintained
၂၂၀.၀၀ US$
+၁၃.၁%
02/25/2026
Last report
၂၀၂၆ ဇူ ၂၈
Fiscal period
Q2 2026
EPS / Est. (USD)
၀.၅၄ US$ / ၀.၅၁ US$
+၆.၂၆%beat
Revenue / Est. (USD)
၂၀.၄၁ ကုဋေ / ၂၀.၄၇ ကုဋေ
-၀.၂၉%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁၈.၈၈ ကုဋေ
၁၉.၇၉ ကုဋေ
၁၉.၄၃ ကုဋေ
၂၀.၄၁ ကုဋေ
Cost of goods sold
၈.၈၃ ကုဋေ
၉.၄၁ ကုဋေ
၈.၆၀ ကုဋေ
၉.၄၁ ကုဋေ
Cost of revenue
၈.၈၃ ကုဋေ
၉.၄၁ ကုဋေ
၈.၆၀ ကုဋေ
၉.၄၁ ကုဋေ
Research and development expenses
၁.၄၂ ကုဋေ
၁.၃၁ ကုဋေ
၁.၄၅ ကုဋေ
၁.၄၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၇.၃၇ ကုဋေ
၇.၄၄ ကုဋေ
၇.၆၅ ကုဋေ
၇.၆၆ ကုဋေ
Operating expense
၈.၇၈ ကုဋေ
၈.၇၅ ကုဋေ
၉.၁၀ ကုဋေ
၉.၁၀ ကုဋေ
Total operating expenses
၁၇.၆၁ ကုဋေ
၁၈.၁၆ ကုဋေ
၁၇.၇၀ ကုဋေ
၁၈.၅၁ ကုဋေ
Operating income
၁.၂၇ ကုဋေ
၁.၆၃ ကုဋေ
၁.၇၃ ကုဋေ
၁.၉၀ ကုဋေ
Other non operating income
-၄.၄၆ သိန်း
-၁.၁၅ ကုဋေ
-၇.၅၀ သိန်း
-၂.၇၃ သိန်း
EBT including unusual items
၁.၇၁ ကုဋေ
၁.၉၁ ကုဋေ
၁.၇၇ သန်း
၁.၄၂ ကုဋေ
EBT excluding unusual items
၁.၃၀ ကုဋေ
၁.၇၆ ကုဋေ
၁.၆၉ ကုဋေ
၁.၉၁ ကုဋေ
Income tax expense
၂.၂၀ သန်း
၅.၈၃ သန်း
-၆.၅၆ သန်း
၉.၁၄ သန်း
Effective tax rate
၁၂.၈၆%
၃၀.၄၈%
-၃၇၀.၂၆%
၆၄.၆၂%
Other operating expenses
-
-
-
-
Net income
၁.၄၉ ကုဋေ
၁.၃၃ ကုဋေ
၈.၃၃ သန်း
၅.၀၁ သန်း
Net profit margin
၇.၉၀%
၆.၇၁%
၄.၂၉%
၂.၄၅%
Earnings per share
၀.၄၆
၀.၄၉
၀.၄၈
၀.၅၄
Interest and investment income
၆.၉၂ သန်း
၆.၇၅ သန်း
၆.၃၄ သန်း
၆.၄၃ သန်း
Interest expense
-၅.၈၃ သန်း
-၅.၉၁ သန်း
-၆.၀၀ သန်း
-၆.၀၈ သန်း
Net interest expenses
၁.၀၉ သန်း
၈.၄၂ သိန်း
၃.၄၅ သိန်း
၃.၄၇ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၃.၂၇ ကုဋေ
၃.၆၃ ကုဋေ
၃.၇၁ ကုဋေ
၃.၈၁ ကုဋေ
Gain or loss from assets sale
-၃.၃၈ သန်း
-
၁.၃၈ ကုဋေ
-၁.၀၃ သိန်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ